Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02713828
Title Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung
Acronym PrE0504
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors PrECOG, LLC.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Miami Hospital Miami Florida 33136 United States Details
Emory University Winship Cancer Institute Atlanta Georgia 30322 United States Details
Ochsner Medical Center New Orleans Louisiana 70121 United States Details
Missouri Valley Cancer Consortium Omaha Nebraska 68106 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Stony Brook University Stony Brook New York 11794-9446 United States Details
Penn State Hershey Cancer Institute Hershey Pennsylvania 17033 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
West Virginia University Morgantown West Virginia 26506 United States Details
Gundersen Health System La Crosse Wisconsin 54601 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field